Single-dose neonatal gene therapy preserves motor coordination and extends survival of Polg-deficient mice
This study demonstrates that a single-dose neonatal gene therapy using AAV vectors successfully preserves motor coordination and extends survival in a newly developed Polg-deficient mouse model, providing preclinical proof of concept for treating POLG-related mitochondrial diseases.